infusion

CVS Caremark to buy Apria's infusion business for $2.1 billion
Reuters
Wed, 11/27/13 - 11:55 am
CVS Caremark
Apria
infusion
devices
M&A
After FDA ban, Hospira creeps back into the infusion game with Q Core deal
FierceMedicalDevice
Wed, 01/23/13 - 09:14 pm
FDA
Hospira
infusion